NCT00216554View on ClinicalTrials.gov

The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2006

Conditions
Bipolar Disorder
Interventions
DRUG

risperidone

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT00216554 - The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania | Biotech Hunter | Biotech Hunter